aluminoxamine has been researched along with aluminum in 15 studies
| Studies (aluminoxamine) | Trials (aluminoxamine) | Recent Studies (post-2010) (aluminoxamine) | Studies (aluminum) | Trials (aluminum) | Recent Studies (post-2010) (aluminum) |
|---|---|---|---|---|---|
| 18 | 2 | 0 | 18,740 | 366 | 5,335 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becaus, I; Boelaert, JR; D'Haese, PC; De Broe, ME; Lamberts, LV; Verpooten, GA | 1 |
| Arnaud, A; Bongiorno, P; Caligaris, F; Canavese, C; Cardelli, R; D'Amicone, M; Gurioli, L; Marchiori, M; Mattiello, G | 1 |
| D'Haese, PC; De Broe, ME; Digenis, PN; Lamberts, LV; Lemoniatou, E; Vasilakakis, DM | 1 |
| Ackrill, P; Day, JP; Hewitt, CD; Hill, K | 1 |
| Weiss, LG | 1 |
| Allain, P; Leblondel, G; Mauras, Y | 1 |
| Allain, P; Ang, KS; Cam, G; Chaleil, D; Le Mignon, L; Mauras, Y; Simon, M; Simon, P | 1 |
| Cameron, EC; Hagen, LE; Hughes, H; Sutton, RA | 1 |
| Ionova, D; Kambova, L; Kirijakov, Z | 1 |
| Arakelian, S; Babloyan, A; D'Haese, PC; De Broe, ME; Digenis, P; Jurgens, A; Lamberts, LV; Tjalma, W; Vaneerdeweg, W; Verpooten, GA | 1 |
| Andriani, M; Nordio, M; Saporiti, E | 1 |
| Günther, K; Klemm, A; Sperschneider, H; Stein, G; Winnefeld, K | 1 |
| Barata, JD; D'Haese, PC; De Broe, ME; Lamberts, LV; Van Landeghem, GF | 1 |
| Blanco-González, E; Cannata-Andía, JB; Fernández-Martín, JL; Menéndez-Fraga, P | 1 |
| Cannata-Andía, JB; Canteros-Picotto, A; Fernández-Martín, JL | 1 |
2 trial(s) available for aluminoxamine and aluminum
| Article | Year |
|---|---|
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Ferric Compounds; Hemosiderosis; Humans; Liver; Middle Aged; Mucormycosis; Organometallic Compounds; Renal Dialysis | 1992 |
Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis.
Topics: Adult; Aluminum; Charcoal; Deferoxamine; Female; Ferric Compounds; Hemoperfusion; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organometallic Compounds; Renal Dialysis | 1992 |
13 other study(ies) available for aluminoxamine and aluminum
| Article | Year |
|---|---|
Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Humans; Iron; Kinetics; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1992 |
Clearance of aluminium desferrioxamine by haemodialysis using a polysulfone high flux membrane.
Topics: Aluminum; Calibration; Cellulose; Chelation Therapy; Creatinine; Deferoxamine; Humans; Membranes, Artificial; Organometallic Compounds; Polymers; Renal Dialysis; Sulfones; Urea | 1989 |
Clinical aspects and applications of hemofiltration.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Aluminum; Bone and Bones; Calcium-Binding Proteins; Cefuroxime; Child; Child, Preschool; Deferoxamine; Female; Hemofiltration; Hemoperfusion; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Osteocalcin; Parathyroid Hormone; Renal Dialysis | 1989 |
Effect of aluminum and deferoxamine on biliary iron elimination in the rat.
Topics: Aluminum; Animals; Bile; Deferoxamine; Iron; Male; Organometallic Compounds; Rats; Rats, Inbred Strains | 1988 |
Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
Topics: Adult; Aluminum; Deferoxamine; Female; Ferric Compounds; Hemochromatosis; Humans; Injections, Intramuscular; Iron; Kinetics; Male; Middle Aged; Organometallic Compounds | 1987 |
Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography.
Topics: Aluminum; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Iron; Kidney Failure, Chronic; Organometallic Compounds; Peritoneal Dialysis, Continuous Ambulatory | 1986 |
Aluminium overload influences cognitive function in patients on dialysis.
Topics: Adult; Aluminum; Brain Diseases; Chelating Agents; Cognition; Deferoxamine; Female; Humans; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1994 |
Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function.
Topics: Aluminum; Animals; Bile; Blood Chemical Analysis; Chelating Agents; Deferoxamine; Dogs; Ferric Compounds; Iron Chelating Agents; Kidney; Male; Organometallic Compounds; Urine | 1994 |
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
Topics: Aluminum; Antidotes; Chelating Agents; Data Interpretation, Statistical; Deferoxamine; Drug Administration Schedule; Ferric Compounds; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1996 |
Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
Topics: Aluminum; Biocompatible Materials; Deferoxamine; Female; Hemofiltration; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Organometallic Compounds; Polycarboxylate Cement; Polymers; Renal Dialysis; Sulfones | 1997 |
Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
Topics: Adult; Aluminum; Citric Acid; Deferoxamine; Female; Humans; Kidney; Male; Middle Aged; Organometallic Compounds; Reference Values; Renal Dialysis; Transferrin | 1997 |
Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
Topics: Aluminum; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Organometallic Compounds; Renal Dialysis; Spectrophotometry, Atomic; Time Factors; Uremia | 1998 |
Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
Topics: Aluminum; Chelating Agents; Chelation Therapy; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Organometallic Compounds; Ultrafiltration | 2000 |